Menu
Back to Archived Journals » Core Evidence » Volume 1-Issues 1 & 2 » Issue 2
Core Evidence ceased publishing in January 2023. All articles that have been published in Core Evidence will continue to be available on the Dove Press site, and will be securely archived with CLOCKSS.
ISSN: 1555-175X
- View all (143)
- Volume 15, 2020 (4)
- Volume 14, 2019 (6)
- Volume 13, 2018 (3)
- Volume 12, 2017 (2)
- Volume 11, 2016 (5)
- Volume 10, 2015 (9)
- Volume 9, 2014 (13)
- Volume 8, 2013 (7)
- Volume 7, 2012 (12)
- Volume 6, 2011 (7)
- Volume 5, 2010 (9)
- Volume 4, 2009 (20)
- Volume 3, 2008 (5)
- Volume 2, 2007 (22)
- Volume 1-Issues 3 & 4, 2006 (8)
- Volume 1-Issues 1 & 2, 2005 (11)
Archive: Volume 1-Issues 1 & 2, 2005
Original Research
Lapatinib: the evidence for its therapeutic value in metastatic breast cancer
Andrew Thomson
Core Evidence 2005, 1-Issues 1 & 2:0-0
Published Date: 30 June 2005
Original Research
Exubera® (inhaled insulin): an evidence-based review of its effectiveness in the management of diabetes
Louise Profit
Core Evidence 2005, 1-Issues 1 & 2:0-0
Published Date: 30 June 2005
Original Research
Topiramate: the evidence for its therapeutic value in the prevention of migraine
Carole Nadin
Core Evidence 2005, 1-Issues 1 & 2:0-0
Published Date: 30 June 2005
Original Research
Dutasteride: an evidence-based review of its clinical impact in the treatment of benign prostatic hyperplasia
Andrew Thomson
Core Evidence 2005, 1-Issues 1 & 2:0-0
Published Date: 30 June 2005
Original Research
Eplerenone: the evidence for its place in the treatment of heart failure after myocardial infarction
Carole Nadin
Core Evidence 2005, 1-Issues 1 & 2:0-0
Published Date: 30 June 2005